Excessive daytime sleepiness in Parkinson’s disease
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Factor SA, Weiner WJ. “Sleep benefit” in Parkinson’s disease. Neurology. 1998; 50: 1514–1515.
2.
Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord. 1990; 5: 280–285.
3.
Friedman A. Sleep pattern in Parkinson’s disease. Acta Med Pol. 1980; 21: 193–199.
4.
Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol. 1988; 11: 512–519.
5.
Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord. 1999; 14: 922–927.
6.
Paus S, Brecht HM, Koster J, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’ disease. Mov Disord. 2003; 18: 659–667.
7.
Hobson DE, Lang AE, Wayne Martin WR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian Movement Disorders Group. JAMA. 2002; 287: 455–463.
8.
Nausieda PA. Sleep in Parkinson’s disease. Koller WC, ed. In: Handbook of Parkinson’s disease. 2nd ed. New York: Marcel Dekker, 1993: 451.
9.
Brodsky MA, Godgold J, Roth T, Olanow CW. Sleepiness in Parkinson’s disease: a controlled study. Mov Disord. 2003; 18: 668–672.
10.
Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 1999; 52: 1908–1910.
11.
Olanow CW, Schapira AHV, Roth T. Waking up to sleep episodes in Parkinson’s disease. Mov Disord. 2000; 15: 212–215.
12.
Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson’s disease: polysomnographic recordings. Mov Disord. 2001; 16: 500–506.
13.
Ulivelli M, Rossi S, Lombardi C, et al. Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology. 2002; 58: 462–465.
14.
Schenck CH, Bundlie SR, Mahowold MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology. 1996; 46: 388–393.
15.
Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia. An association likely reflecting Lewy body disease. Neurology. 1998; 51: 363–370.
16.
Pappert EJ, Goetz CG, Niederman FC, et al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease. Mov Disord. 1999; 14: 117–121.
17.
Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology. 1997; 48: 1094–1097.
18.
Jellinger KA. Pathology of Parkinson’s disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol. 1991; 14: 153–197.
19.
Rye D, Bliwise D. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts R, Koller W, eds. Movement disorders: neurologic principles and practice. New York: McGraw-Hill, 1997: 687–713.
20.
van Hilten B, Hoff JI, Middelkoop HA, et al. Sleep disruption in Parkinson’s disease. Assessment by continuous activity monitoring. Arch Neurol. 1994; 51: 922–928.
21.
Wetter TC, Collado-Seidel V, Pollmaecher T, et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep. 2000; 23: 361–367.
22.
Happe S, Schrodl B, Faltl M, et al. Sleep disorders and depression in patients with Parkinson’s disease. Acta Neurol Scand. 2001; 104: 275–280.
23.
Starkstein SE, Preziosi TJ, Robinson RG. Sleep disorders, pain, and depression in Parkinson’s disease. Eur Neurol. 1991; 31: 352–355.
24.
Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord. 2000; 15: 658–663.
25.
Happe S, Pirker W, Sauter C, et al. Successful treatment of excessive daytime sleepiness in Parkinson’s disease with modafinil. J Neurol. 2001; 248: 632–634.
26.
Chaudhuri RK, Bhattacharya K, Porter MC, et al. The use of cabergoline in nocturnal Parkinsonian disabilities causing sleep disruption: a parallel study with controlled release levodopa. Eur J Neurol. 1999; 6 (suppl 5): S11–15.
27.
Reuter I, Ellis CM, Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson’s disease and restless legs syndrome. Acta Neurol Scand. 1999; 100: 163–167.
28.
Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behavior disorder. Demographic, clinical and laboratory findings in 93 cases. Brain. 2000; 123: 331–339.
29.
Tan A, Salgado M, Fahn S. Rapid eye movement sleep behaviour disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord. 1996; 11: 214–216.
30.
The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med. 1999; 340: 757–763.
Information & Authors
Information
Published In
Copyright
© 2004.
Publication History
Published online: October 25, 2004
Published in print: October 26, 2004
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Different risks of early-onset and late-onset Parkinson disease in individuals with mental illness, npj Parkinson's Disease, 10, 1, (2024).https://doi.org/10.1038/s41531-023-00621-x
- ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein, International Journal of Molecular Sciences, 24, 2, (1775), (2023).https://doi.org/10.3390/ijms24021775
- Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity, Frontiers in Neuroscience, 12, (2018).https://doi.org/10.3389/fnins.2018.00081
- Sex differences in sleep apnea and comorbid neurodegenerative diseases, Steroids, 133, (28-33), (2018).https://doi.org/10.1016/j.steroids.2017.12.006
- Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease, International Journal of Neuroscience, 126, 5, (422-428), (2015).https://doi.org/10.3109/00207454.2015.1023437
- Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease, Expert Review of Neurotherapeutics, 15, 9, (1053-1065), (2015).https://doi.org/10.1586/14737175.2015.1077703
- Sleep disorders in Parkinson's disease, Postępy Psychiatrii i Neurologii, 24, 3, (147-155), (2015).https://doi.org/10.1016/j.pin.2015.08.002
- Dopamine agonists in Parkinson’s disease, Expert Review of Neurotherapeutics, 8, 4, (671-677), (2014).https://doi.org/10.1586/14737175.8.4.671
- Sleep Disturbances and Parkinson's Disease, CNS Spectrums, 13, S4, (12-17), (2014).https://doi.org/10.1017/S1092852900017272
- Excessive Sleepiness in Parkinson's Disease: A Wake-Up Call, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 34, 4, (401-401), (2014).https://doi.org/10.1017/S0317167100007253
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.